brand-logo
International Women’s Day 2024

International Women's Day 2024 This International Women's Day (IWD), we're taking the opportunity to put the spotlight on some of the incredible leaders and role models within our business. With women making up over 80% of our workforce, we are…

Biometrics team takes shape at Accelagen

Biometrics team takes shape at Accelagen In a world increasingly driven by data, the ability to accurately interpret and effectively utilise complex information in meaningful ways is crucial. Over the last few years, Accelagen has proudly built an expert Biometrics…

Leveraging the Australian Advantage: Benefits of Running Clinical Trials Down Under

Leveraging the Australian Advantage: Benefits of Running Clinical Trials Down Under Clinical trials are at the heart of groundbreaking medical advancements, and choosing the right location for these trials can significantly impact their success. Australia, with its unique combination of…

Unlocking the Power of Research: What is a CRO and What Makes Accelagen Stand Out

Unlocking the Power of Research: What is a CRO and What Makes Accelagen Stand Out In the ever-evolving landscape of healthcare and pharmaceuticals, Contract Research Organisations (CROs) play a pivotal role in bringing innovative and life-saving treatments to market and,…

Unlocking Potential Through In-House Professional Development

Unlocking Potential Through In-House Professional Development In today's rapidly evolving professional landscape, fostering in-house development and empowering employees with upskilling opportunities has become a strategic imperative for forward-thinking organisations like Accelagen.Gone are the days when a career path meant a…

Synergy Across Regulatory Affairs and Clinical Research: A Dynamic Approach to Optimising Drug Development

Synergy Across Regulatory Affairs and Clinical Research: A Dynamic Approach to Optimising Drug Development Explore the synergy between Regulatory Affairs and Clinical Research, driving optimal drug development and promoting advancements in healthcare.The puzzle that is pharmaceutical drug development can be…

Accelerating Beyond: 2023 Accelagen Team Conference

Accelerating Beyond: 2023 Accelagen Team Conference “Don’t tell me the sky’s the limit when there’s footprints on the moon.” - Paul Brandt Last week, our team came together for Accelagen’s annual Conference - usually a space and time dedicated to…

Australians benefit from first-ever cancer trial

Australians benefit from first-ever cancer trial, non-invasive solid tumour evaluation at Olivia Newton John Cancer Centre: iPREDICT Study Leading AU-based Contract Research Organisation (CRO) Accelagen collaborates with US-based ImaginAb to sponsor and conduct trials, highlighting Australia’s growing attractiveness for ground-breaking…

Rapid growth puts Australian CRO Accelagen on the map

Rapid growth puts Australian CRO Accelagen on the map for clinical research globally With over 110% revenue growth in the last two years, Accelagen announces move to new office space in Hawthorn East, MelbourneSeptember 2022 - Accelagen, a leading Australian…